Exploring the Antimicrobial Potential of Hallachrome, a Defensive Anthraquinone from the Marine Worm Halla parthenopeia (Polychaeta)

Antimicrobial resistance is a critical global health issue, with rising resistance among bacteria and fungi. Marine organisms have emerged as promising, but underexplored, sources of new antimicrobial agents. Among them, marine polychaetes, such as , which possess chemical defenses, could attract si...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 22; no. 9; p. 380
Main Authors Ferri, Anita, Simonini, Roberto, Sabia, Carla, Iseppi, Ramona
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.09.2024
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antimicrobial resistance is a critical global health issue, with rising resistance among bacteria and fungi. Marine organisms have emerged as promising, but underexplored, sources of new antimicrobial agents. Among them, marine polychaetes, such as , which possess chemical defenses, could attract significant research interest. This study explores the antimicrobial properties of hallachrome, a unique anthraquinone found in the purple mucus of , against Gram-negative bacteria ( ATCC 25922, ATCC 9027), Gram-positive bacteria ( ATCC 29212, ATCC 6538, ATCC 12228), and the most common human fungal pathogen ATCC 10231. Antibacterial susceptibility testing revealed that Gram-negative bacteria were not inhibited by hallachrome at concentrations ≤2 mM. However, Gram-positive bacteria showed significant growth inhibition at 0.12-0.25 mM, while was inhibited at 0.06 mM. Time-kill studies demonstrated dose-dependent growth inhibition of susceptible strains by hallachrome, which exerted its effect by altering the membrane permeability of , , and after 6 h and after 24 h. Additionally, hallachrome significantly reduced biofilm formation and mature biofilm in , , and . Additionally, it inhibited hyphal growth in . These findings highlight hallachrome's potential as a novel antimicrobial agent, deserving further exploration for clinical experimentation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1660-3397
1660-3397
DOI:10.3390/md22090380